549 results
Page 14 of 28
8-K/A
EX-10.1
nx97 5vmmfc55zp
11 May 12
Departure of Directors or Certain Officers
12:00am
424B5
swpb6fpl
19 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
3j4 dn1hbhfu3
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
sw1ztlwuhyz1fs9o49of
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
h17917n bw8izll
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
424B5
cvk47g
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
g613ewgkywkrz7 rcjf
14 Dec 11
Entry into a Material Definitive Agreement
12:00am